- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06399627
Effect of Non-anemic Iron Deficiency on Outcome Following Off-pump Coronary Revascularization
This is a single center retrospective study of patients who underwent off pump coronary artery bypass surgery between 2016.11~2023.05. From this patient group, preoperatively non-anemic patients were selected and were divided into 2 cohorts according to their preoperative iron status; iron replete and iron deficient. These two cohorts were compared to evaluate the effect of preoperative iron deficiency on patient outcomes.
The primary end point was the occurrence of composite morbidity/mortality end points which were: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction. Occurrence of any one of these outcomes counted as primary end point met. Secondary outcome was to evaluate and compare hemoglobin recovery of iron replete and deficient patients until one year after surgery.
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03722
- Recruiting
- Yonsei University Health System, Severance Hospital
-
Contact:
- seohee Ko
- Phone Number: 82-10-9345-6520
- Email: shk0207@yuhs.ac
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who received off pump coronary artery bypass surgery (OPCAB) between 2016.11.01-2023.05.31
Exclusion Criteria:
- preoperative anemia (male Hb <13g/dL, female Hb<12g/dL)
- emergency surgery
- redo-off pump coronary artery bypass surgery
- minimally invasive coronary artery bypass surgery
- OPCAB in conjunction with other cardiac surgical procedures (e.g. valve surgery, graft replacement surgery of the aorta)
- intraoperative on pump conversion
- lack of sufficient preoperative data (ferritin, transferrin saturation, C-reactive protein) to determine iron status
- administration of intravenous iron within 4 weeks or parenteral iron of more than 2 weeks prior to surgery
- enrollemnt in other clinical studies
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Iron replete
Patient who did not meet the criteria for iron deficiency (see below)
|
|
Iron deficient
patients with preoperative iron profile of either of the following were defined as iron deficient:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with in hospital mortality, stroke, deep sternal infection, hemostatic reoperation, delirium
Time Frame: from the end of surgery until patient discharge (assessed up to day 60)
|
This outcome is a composite of the following: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction.
The occurrence of any one of these was regarded as primary end point met.
|
from the end of surgery until patient discharge (assessed up to day 60)
|
|
Number of participants with acute kidney injury
Time Frame: until 7 days after surgery
|
This outcome is a composite of the following: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction.
The occurrence of any one of these was regarded as primary end point met.
|
until 7 days after surgery
|
|
Number of participants with post operative myocardial infarction
Time Frame: until 48 hours post-surgery
|
This outcome is a composite of the following: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction.
The occurrence of any one of these was regarded as primary end point met.
|
until 48 hours post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post discharge hemoglobin
Time Frame: Until 1 year after surgery
|
Data of hemoglobin levels after discharge until 1 year after surgery was collected to evaluate hemoglobin recovery to preoperative baseline levels.
|
Until 1 year after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2022-1112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.